I am a mathematical biologist and a bioinformatics researcher in the pharmaceutical industry. I received my Ph.D. in Life Science from Hokkaido University in March 2025.
I study biological dynamics using mathematical models and data analysis, with an interest in pharmacometrics and systems biology.
ORCIDGoogle ScholarLinkedInGitHub
A Japanese guide comparing purposes, input data, model development, diagnostics and limits of PK/PD, population PK, PBPK and QSP. Three original figures include hypothetical PK/PD dynamics and analytical conditional population distributions. No empirical model estimation or real-drug validation is claimed.
Conditional simulations compare ADC and unconjugated DXd under equal total input. Finite-horizon AUC, late-window exposure and unvalidated formation-clock extrapolation are distinguished; clinical benefit is not inferred.
A known-motif audit of two public phage genomes separates sequence-pattern verification from autonomous discovery. Reported campaign counts, identifier-limited zero recoveries in ten reruns and fixed-input recognition are kept distinct from molecular function.